Dimensional Fund Advisors’s aTyr Pharma ATYR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $71.5K | Sell |
91,871
-5,626
| -6% | -$4.75K | ﹤0.01% | 3144 |
|
|
2025
Q4 | $76.2K | Sell |
97,497
-117,049
| -55% | -$96.1K | ﹤0.01% | 3180 |
|
|
2025
Q3 | $155K | Hold |
214,546
| – | – | ﹤0.01% | 3152 |
|
|
2025
Q2 | $1.09M | Sell |
214,546
-13,548
| -6% | -$53.3K | ﹤0.01% | 2871 |
|
|
2025
Q1 | $689K | Sell |
228,094
-15,275
| -6% | -$55.7K | ﹤0.01% | 2953 |
|
|
2024
Q4 | $881K | Buy |
243,369
+97,845
| +67% | +$296K | ﹤0.01% | 2943 |
|
|
2024
Q3 | $256K | Hold |
145,524
| – | – | ﹤0.01% | 3132 |
|
|
2024
Q2 | $227K | Sell |
145,524
-51,220
| -26% | -$89.1K | ﹤0.01% | 3145 |
|
|
2024
Q1 | $384K | Buy |
196,744
+54,496
| +38% | +$95.1K | ﹤0.01% | 3085 |
|
|
2023
Q4 | $201K | Sell |
142,248
-94,201
| -40% | -$121K | ﹤0.01% | 3194 |
|
|
2023
Q3 | $374K | Sell |
236,449
-41,355
| -15% | -$76.5K | ﹤0.01% | 3101 |
|
|
2023
Q2 | $600K | Buy |
277,804
+130,031
| +88% | +$284K | ﹤0.01% | 3025 |
|
|
2023
Q1 | $310K | Sell |
147,773
-49,919
| -25% | -$109K | ﹤0.01% | 3113 |
|
|
2022
Q4 | $433 | Buy |
197,692
+28,332
| +17% | +$66.8K | ﹤0.01% | 3065 |
|
|
2022
Q3 | $508K | Buy |
169,360
+21,764
| +15% | +$72.9K | ﹤0.01% | 3043 |
|
|
2022
Q2 | $418K | Sell |
147,596
-54,688
| -27% | -$198K | ﹤0.01% | 3100 |
|
|
2022
Q1 | $1.08M | Sell |
202,284
-24,428
| -11% | -$138K | ﹤0.01% | 2975 |
|
|
2021
Q4 | $1.69M | Buy |
226,712
+2,433
| +1% | +$20.3K | ﹤0.01% | 2891 |
|
|
2021
Q3 | $2.04M | Buy |
224,279
+3,351
| +2% | +$20K | ﹤0.01% | 2852 |
|
|
2021
Q2 | $1.08M | Buy |
220,928
+156,528
| +243% | +$667K | ﹤0.01% | 3017 |
|
|
2021
Q1 | $287K | Buy |
64,400
+45,270
| +237% | +$213K | ﹤0.01% | 3236 |
|
|
2020
Q4 | $74K | Hold |
19,130
| – | – | ﹤0.01% | 3294 |
|
|
2020
Q3 | $62K | Buy |
19,130
+2,500
| +15% | +$10.3K | ﹤0.01% | 3293 |
|
|
2020
Q2 | $74K | Sell |
16,630
-11,294
| -40% | -$41K | ﹤0.01% | 3292 |
|
|
2020
Q1 | $78K | Buy |
+27,924
| New | +$121K | ﹤0.01% | 3293 |
|
|
2018
Q2 | – | Sell |
-8,175
| Closed | -$303K | – | 3380 |
|
|
2018
Q1 | $303K | Buy |
8,175
+2,050
| +33% | +$96.1K | ﹤0.01% | 3176 |
|
|
2017
Q4 | $300K | Buy |
6,125
+136
| +2% | +$8.36K | ﹤0.01% | 3162 |
|
|
2017
Q3 | $423K | Buy |
5,989
+1,834
| +44% | +$85K | ﹤0.01% | 3126 |
|
|
2017
Q2 | $201K | Hold |
4,155
| – | – | ﹤0.01% | 3198 |
|
|
2017
Q1 | $204K | Buy |
4,155
+200
| +5% | +$9.14K | ﹤0.01% | 3202 |
|
|
2016
Q4 | $119K | Hold |
3,955
| – | – | ﹤0.01% | 3228 |
|
|
2016
Q3 | $176K | Buy |
+3,955
| New | +$171K | ﹤0.01% | 3193 |
|
Other funds holding ATYR
VCM
GCP
Dimensional Fund Advisors's ATYR Position: Q1 2026 in Review
Dimensional Fund Advisors reduced its aTyr Pharma (ATYR) stake by 5.8% in Q1 2026, selling an estimated $4.75K and leaving 91,871 shares worth $71.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3144.
Dimensional Fund Advisors first reported a position in ATYR in Q3 2016 and has held it in 32 quarters since. The position peaked at $2.04M in Q3 2021. 111 funds tracked by Wall St. Rank hold ATYR as of Q1 2026.
- Dimensional Fund Advisors held 91,871 shares of aTyr Pharma worth $71.5K as of Q1 2026.
- Dimensional Fund Advisors sold 5,626 aTyr Pharma shares in Q1 2026, an estimated $4.75K.
- aTyr Pharma made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #3144 holding.
- Dimensional Fund Advisors first reported a position in aTyr Pharma in Q3 2016 and has held it in 32 quarters since.
- Dimensional Fund Advisors's aTyr Pharma position peaked at $2.04M in Q3 2021.
- 111 funds tracked by Wall St. Rank held aTyr Pharma as of Q1 2026.
Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.